Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamictal Augmentation of Haloperidol Decanoate in Resistant Schizophrenia
NCT00947375Phase 4Terminated
- Sponsor
- Central Mental Clinic for Outpatients of Baku City
- Start
- Jan 2005
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lamotrigine in schizophrenia, sponsored by Central Mental Clinic for Outpatients of Baku City. Started Jan 2005; status: terminated.
02
Drugs
lamotrigine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00947375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00947375.